RecruitingNCT06567431

Blood And Tears in Alzheimer's Disease

Examination of Alzheimer's Disease Biomarkers in Tears and Dry Blood Spots


Sponsor

Danish Dementia Research Centre

Enrollment

600 participants

Start Date

Mar 18, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to investigate whether biomarkers of Alzheimer's disease can be found in tearfluid, as well as dried bloodspots in patients with Alzheimer's disease, other dementia diagnoses compared to controls.


Eligibility

Min Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This study explores whether a simple blood test and a tear sample can help diagnose Alzheimer's disease and other brain diseases as accurately as the current spinal fluid test. The goal is to find easier, less invasive ways to detect these conditions early. **You may be eligible if:** - You are a legal adult - You are having or have already had a spinal fluid (lumbar puncture) sample taken - You have been diagnosed with Alzheimer's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, or normal pressure hydrocephalus — OR you are a healthy person with no neurological disease who is also undergoing a lumbar puncture **You may NOT be eligible if:** - You are not having a lumbar puncture - Your doctor considers you medically unfit to take part Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Danish Dementia Research Centre

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06567431


Related Trials